Hamilton Thorne (TSE:HTL) has released an update.
Hamilton Thorne Ltd, a key player in ART and cell biology sectors, has sent out key documents to its shareholders for a special meeting to vote on a going-private deal, offering C$2.25 per share. The deal also aligns with plans to acquire Cook Medical’s ART product line, enhancing the company’s portfolio. Shareholder approval is crucial for the transaction, which requires a two-thirds majority vote, excluding certain minority votes, to pass.
For further insights into TSE:HTL stock, check out TipRanks’ Stock Analysis page.
